Literature DB >> 30058593

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus.

Wen-Ming Wang1, Kevin Yu Wang2, Tao Wang1, Hong-Zhong Jin1, Kai Fang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30058593      PMCID： PMC6071463          DOI： 10.4103/0366-6999.237411

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  5 in total

1.  Imiquimod-induced Psoriatic Erythroderma Treated with Infliximab.

Authors:  Reiko Tsutsumi; Yuichi Yoshida; Osamu Yamamoto
Journal:  Acta Derm Venereol       Date:  2017-02-08       Impact factor: 4.437

2.  Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population.

Authors:  Yang Li; Hui Cheng; Xian-bo Zuo; Yu-jun Sheng; Fu-sheng Zhou; Xian-fa Tang; Hua-yang Tang; Jin-ping Gao; Zheng Zhang; Su-ming He; Yong-mei Lv; Kun-ju Zhu; Da-yan Hu; Bo Liang; Jun Zhu; Xiao-dong Zheng; Liang-dan Sun; Sen Yang; Yong Cui; Jian-jun Liu; Xue-jun Zhang
Journal:  J Med Genet       Date:  2013-09-26       Impact factor: 6.318

3.  Psoriasis in systemic lupus erythematosus: a single-center experience.

Authors:  Konstantinos Tselios; Kristy Su-Ying Yap; Rattapol Pakchotanon; Ari Polachek; Jiandong Su; Murray B Urowitz; Dafna D Gladman
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

Review 4.  Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.

Authors:  Haran Yogasundaram; Brendan N Putko; Julia Tien; D Ian Paterson; Bibiana Cujec; Jennifer Ringrose; Gavin Y Oudit
Journal:  Can J Cardiol       Date:  2014-08-23       Impact factor: 5.223

5.  Treatment of coexistent psoriasis and lupus erythematosus.

Authors:  Sowmya Varada; Alice B Gottlieb; Joseph F Merola; Ami R Saraiya; Suzanne J Tintle
Journal:  J Am Acad Dermatol       Date:  2014-12-06       Impact factor: 11.527
  5 in total
  5 in total

1.  Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.

Authors:  Işın Nur Sultan Öncü; Dilara Güler; Gülhan Gürel
Journal:  Dermatol Ther       Date:  2021-02-24       Impact factor: 3.858

2.  Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.

Authors:  Muskaan Sachdeva; Asfandyar Mufti; Khalad Maliyar; Yuliya Lytvyn; Jensen Yeung
Journal:  J Am Acad Dermatol       Date:  2020-05-19       Impact factor: 11.527

3.  Effectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials.

Authors:  Jing-Zhan Zhang; Yuan Ding; Fang Xiang; Shi-Rong Yu; De-Zhi Zhang; Meng-Meng Guan; Xiao-Jing Kang
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

4.  Hydroxychloroquine-induced erythroderma: A rare adverse effect of a commonly used drug.

Authors:  Ananta Khurana; Anusha Katare; Aastha Agarwal; Priyadharshini Kathirvel; Arvind Ahuja
Journal:  Dermatol Ther       Date:  2020-09-08       Impact factor: 3.858

Review 5.  Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

Authors:  Antonio Martinez-Lopez; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Am Acad Dermatol       Date:  2020-08-07       Impact factor: 11.527
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.